Abbott Laboratories is a global healthcare company headquartered in Abbott Park, Illinois, that develops, manufactures and markets a broad portfolio of medical products and services. Founded in 1888, Abbott operates through multiple business areas that focus on diagnostics, medical devices, nutritionals and established pharmaceuticals. The company supplies hospitals, clinics, laboratories, retailers and direct-to-consumer channels with products intended to diagnose, treat and manage a wide range of health conditions.
In diagnostics, Abbott provides laboratory and point-of-care testing platforms and assays used to detect infectious diseases, chronic conditions and biomarkers; its Alinity family of instruments and rapid-test solutions are examples of this capability. The medical devices business includes cardiac and vascular products, structural heart therapies, neuromodulation and diabetes-care technologies, notably continuous glucose monitoring systems and insulin-delivery adjuncts. Abbott’s nutrition portfolio features infant formulas, adult nutritional supplements and pediatric nutrition brands designed for clinical and retail settings. The company’s established pharmaceuticals unit develops and markets a range of branded generic medicines in selected international markets.
Abbott has a long corporate history and has reshaped its business through strategic transactions, including a 2013 corporate separation that created AbbVie as an independent research-driven pharmaceutical company and a 2017 acquisition that broadened its medical-device offerings. These moves, together with ongoing investments in research and product development, reflect Abbott’s focus on innovation across diagnostics, devices, nutrition and pharmaceuticals.
Today Abbott serves a global footprint, with products marketed in many countries around the world. The company is led by President and Chief Executive Officer Robert B. Ford and maintains research, manufacturing and distribution operations to support healthcare providers, laboratories, retailers and consumers. Abbott emphasizes collaboration with the medical community and regulatory bodies to advance product availability and patient care worldwide.